Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Up 264.6% in August

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the target of a large growth in short interest in August. As of August 31st, there was short interest totaling 8,040 shares, a growth of 264.6% from the August 15th total of 2,205 shares. Based on an average daily volume of 13,403 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.0% of the shares of the stock are sold short.

Analyst Ratings Changes

Separately, UBS Group cut shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Nihon Kohden Stock Up 4.7%

OTCMKTS:NHNKY traded up $0.45 during midday trading on Friday, hitting $10.01. The company had a trading volume of 18,352 shares, compared to its average volume of 9,907. The company has a market capitalization of $1.68 billion, a PE ratio of 18.20 and a beta of 0.36. Nihon Kohden has a 52-week low of $8.12 and a 52-week high of $14.21. The stock’s fifty day moving average price is $9.51 and its 200-day moving average price is $9.41.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.09). Nihon Kohden had a return on equity of 9.08% and a net margin of 5.90%.The firm had revenue of $297.47 million for the quarter, compared to the consensus estimate of $299.98 million. As a group, research analysts forecast that Nihon Kohden will post 0.6 earnings per share for the current year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and sells electronic medical equipment and related services. Founded in 1951, the company focuses on technologies used to monitor, diagnose and support patients across hospitals and other healthcare settings.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs, defibrillators, automated external defibrillators, ventilators and other critical-care equipment.